<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Perioperative thrombotic risk</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Perioperative thrombotic risk</h1>
<div class="graphic"><div class="figure"><div class="ttl">Perioperative thrombotic risk</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1" rowspan="2">Thrombotic risk</td> <td class="subtitle1" colspan="3">Indication for anticoagulant therapy</td> </tr> <tr> <td class="subtitle2">Mechanical heart valve</td> <td class="subtitle2">Atrial fibrillation</td> <td class="subtitle2">VTE</td> </tr> <tr> <td>High thrombotic risk*</td> <td> <p>Any mitral valve prosthesis</p> <p>Any caged-ball or tilting disc aortic valve prosthesis</p> Recent (within 6 months) stroke or transient ischemic attack</td> <td> <p>CHADS<sub>2</sub> <span style="white-space: nowrap;">score 5-6</span></p> <p>CHA<sub>2</sub>DS<sub>2</sub>-VASc <span style="white-space: nowrap;">score 7-9</span></p> <p>Recent (within 3 months) stroke or transient ischemic attack</p> Rheumatic valvular heart disease</td> <td> <p>Recent (within 3 months) VTE</p> Severe thrombophilia (eg, deficiency of protein C, protein S, or antithrombin; antiphospholipid antibodies; multiple abnormalities)</td> </tr> <tr> <td>Moderate thrombotic risk</td> <td>Bileaflet aortic valve prosthesis and 1 or more of the of following risk factors: atrial fibrillation, prior stroke or transient ischemic attack, hypertension, diabetes, congestive heart failure, age &gt;75 years</td> <td> <p>CHADS<sub>2</sub> <span style="white-space: nowrap;">score 3-4</span></p> CHA<sub>2</sub>DS<sub>2</sub>-VASc <span style="white-space: nowrap;">score 4-6</span></td> <td> <p>VTE within the past 3 to 12 months</p> <p>Nonsevere thrombophilia (eg, heterozygous factor V Leiden or prothrombin gene mutation)</p> <p>Recurrent VTE</p> Active cancer (treated within 6 months or palliative)</td> </tr> <tr> <td>Low thrombotic risk</td> <td>Bileaflet aortic valve prosthesis without atrial fibrillation and no other risk factors for stroke</td> <td> <p>CHADS<sub>2</sub> <span style="white-space: nowrap;">score 0-2</span></p> CHA<sub>2</sub>DS<sub>2</sub>-VASc <span style="white-space: nowrap;">score 0-3</span> (assuming no prior stroke or transient ischemic attack)</td> <td>VTE &gt;12 months previous and no other risk factors</td> </tr> </tbody></table></div><div class="graphic_lgnd">The risk classification is largely based on indirect evidence and is intended to be used as a starting point to estimate risk. Patient-specific factors and clinical judgment should also be incorporated into the risk estimate. The source guideline used CHADS<sub>2</sub> scores for risk estimation; additional information from CHA<sub>2</sub>DS<sub>2</sub>-VASc scores may also inform risk, but these scores have not been directly compared in a clinical trial. Refer to UpToDate topics on perioperative anticoagulation management for details.</div><div class="graphic_footnotes">VTE: venous thromboembolism; CHADS<sub>2</sub>: congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, and stroke or transient ischemic attack; CHA<sub>2</sub>DS<sub>2</sub>-VASc: congestive heart failure, hypertension, age ≥75 years (2 points), diabetes mellitus, prior stroke or transient ischemic attack or thromboembolism (2 points), vascular disease (peripheral artery disease, myocardial infarction, or aortic plaque), age 65 to 74 years, sex category female.<br/>
* Very high-risk patients may also include those with a prior stroke or transient ischemic attack occurring &lt;3 months before the planned surgery and a CHADS<sub>2</sub> <span style="white-space: nowrap;">score &gt;5</span> or CHA<sub>2</sub>DS<sub>2</sub>-VASc <span style="white-space: nowrap;">score &gt;6</span> (those with prior thromboembolism during temporary interruption of anticoagulation, or those undergoing certain types of surgery associated with an increased risk for stroke or other thromboembolism [eg, cardiac valve replacement, carotid endarterectomy, major vascular surgery]).</div><div class="graphic_reference">Modified from Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl):e326S. Copyright © 2012. Reproduced with permission from the American College of Chest Physicians.</div><div id="graphicVersion">Graphic 86930 Version 7.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
